- Home
- PCOR vs QGEN Comparison
PCOR vs QGEN Comparison
Compare PCOR & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCOR
- QGEN
- Stock Information
- Founded
- PCOR 2003
- QGEN 1986
- Country
- PCOR United States
- QGEN Netherlands
- Employees
- PCOR N/A
- QGEN N/A
- Industry
- PCOR Computer Software: Prepackaged Software
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PCOR Technology
- QGEN Health Care
- Exchange
- PCOR Nasdaq
- QGEN Nasdaq
- Market Cap
- PCOR 9.9B
- QGEN 9.1B
- IPO Year
- PCOR 2021
- QGEN 1996
- Fundamental
- Price
- PCOR $67.12
- QGEN $45.14
- Analyst Decision
- PCOR Buy
- QGEN Buy
- Analyst Count
- PCOR 22
- QGEN 8
- Target Price
- PCOR $79.45
- QGEN $50.53
- AVG Volume (30 Days)
- PCOR 1.1M
- QGEN 1.5M
- Earning Date
- PCOR 05-01-2025
- QGEN 05-07-2025
- Dividend Yield
- PCOR N/A
- QGEN 2.92%
- EPS Growth
- PCOR N/A
- QGEN N/A
- EPS
- PCOR N/A
- QGEN 0.42
- Revenue
- PCOR $1,192,912,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- PCOR $14.00
- QGEN $6.11
- Revenue Next Year
- PCOR $13.33
- QGEN $6.10
- P/E Ratio
- PCOR N/A
- QGEN $107.32
- Revenue Growth
- PCOR 18.59
- QGEN 3.31
- 52 Week Low
- PCOR $49.46
- QGEN $37.63
- 52 Week High
- PCOR $88.92
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- PCOR 49.98
- QGEN 66.03
- Support Level
- PCOR $66.07
- QGEN $41.77
- Resistance Level
- PCOR $68.71
- QGEN $43.01
- Average True Range (ATR)
- PCOR 1.74
- QGEN 0.70
- MACD
- PCOR -0.34
- QGEN 0.24
- Stochastic Oscillator
- PCOR 14.62
- QGEN 93.82
About PCOR Procore Technologies Inc.
Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).